White matter hyperintensity drives EEG microstate abnormalities in arteriosclerotic cerebral small vessel disease

Kaiyan Feng1, Jiaxin Cai2, Jianming Lei3

  • 1Department of Neurology, Maoming People's Hospital, Maoming, China.

Abstract

Insights

Electroencephalography (EEG) microstate alterations correlate with white matter hyperintensity (WMH) burden and cognitive decline in dementia. These EEG biomarkers show potential for diagnosing WMH-related dementia.

Area of Science:

  • Neuroscience
  • Medical Imaging
  • Biomarkers

Background:

  • White matter hyperintensity (WMH) on MRI indicates cerebrovascular disease but lacks sensitivity to early pathophysiological changes.
  • Existing imaging methods struggle to capture the subtle neural network disruptions underlying WMH-related cognitive impairment.

Purpose of the Study:

  • To investigate electroencephalography (EEG) microstate alterations in patients with WMH.
  • To identify potential EEG biomarkers for differentiating WMH with dementia (WMHD) from WMH without dementia (WMH-ND) and healthy controls (HC).

Main Methods:

  • A cross-sectional study involving 90 participants (30 WMHD, 30 WMH-ND, 30 HC).
  • MRI for WMH volume quantification and resting-state EEG for microstate analysis (occurrence, duration, coverage, transition probabilities).
  • Partial correlation and machine learning models (SVM, LR) were used to assess associations and build classification predictors.

Main Results:

  • WMHD and WMH-ND groups showed altered EEG microstate temporal parameters, particularly reduced microstate C.
  • Microstate parameters correlated significantly with WMH volume and cognitive scores (MMSE).
  • Machine learning models achieved high accuracy (up to 79.17%) and AUC (up to 0.86) in classifying groups, with SVM and LR performing best for WMHD vs. WMH-ND.

Conclusions:

  • EEG microstate analysis reveals significant alterations linked to WMH burden and cognitive function.
  • These findings suggest EEG microstate features are promising biomarkers for WMH-related dementia.
  • The developed classification models demonstrate potential for clinical application in diagnosing WMH-related cognitive impairment.